Risk of tuberculosis in dialysis patients: Association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis

International Urology and Nephrology

Volumn 38, Issue 3-4, 2006, Pages 745-751

  Christopoulos, A I ^a   Diamantopoulos, A A ^a   Dimopoulos, P A ^b   Gumenos, D S ^b   Barbalias, G A ^c  

^a St Andrews General State Hospital   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

2,4 dinitrochlorobenzene; Anergy; Anergy testing; Dialysis; Mantoux; Renal patients; Risk of tuberculosis; Tuberculin sensitivity; Tuberculosis

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BCG VACCINE; TUBERCULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CLONAL ANERGY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; SKIN TEST; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; DINITROCHLOROBENZENE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SKIN TESTS; TUBERCULIN; TUBERCULOSIS;

EID: 33847382923     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-9051-3     Document Type: Article

References (18)

1. Descamps-Latsca B (1993) The immune system in end-stage renal disease. Cur Opin Nephrol Hypertens 2(6):883-895
2. American Thoracic Society, Centers for Disease Control (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161(Suppl):S221-S228
3. Reider HL (2002) Interventions for tuberculosis control and elimination. Preventive chemotherapy. International Union against Tuberculosis and Lung Disease. chapter 4:127-146
4. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34:187-220
5. Pradhan RP, Katz LA, Nidus BD et al (1974) Tuberculosis in dialyzed patients. JAMA 229:798
6. Hussein MM, Mooij JM, Roujouleh H (2003) Tuberculosis and chronic renal disease. Semin Dial 16(1):38-44
7. Cohn DL (2003) Treatment of latent tuberculosis infection. Semin Respir Infect 18(4):249-262
8. Korzets A, Gafter U (1999) Tuberculosis prophylaxis for the chronically dialysed patient. Nephrol Dial Transplant 14:2857-2859
9. Tuberculosis Research Center (ICMR), Chennai, India. Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in South India: A 15 year follow-up. Int J Tuberc Lung Dis 7(11):1083-1091
10. Fang HC, Chou KJ, Chen CL, et al (2002) Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area. Nephron 91(4):682-687
11. Woeltje KF, Mathew A, Rothstein M et al (1998) Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 31(5):848-852
12. Slovis BS, Plitman JD, Haas DW (2000) The case against anergy testing as a routine adjunct to tuberculin skin testing. JAMA 283(15):2003-2007
13. Malaviya AN, Sehgal KL, Kumar R, Dingley HB (1975) Factors of delayed hypersensitivity in pulmonary tuberculosis. Am Respir Dis 112(1):49-52
14. Yoneda T, Mikami R, Sakaguchi Y, Shirai F. The relationship between natural killer cell activity and delayed-type hypersensitivity reaction to 2,4-dinitrochlorbenzene in the spectrum of chronic, intractable pulmonary tuberculosis
15. Watson M, Briggs J, Diamantopoulos A (1979) Endogenous cell-mediated immunity and outcome of renal transplantation. Lancet 22/29, 1323
16. Millard PS, Wilcosky TC, Reade-Cristopher SJ, Weber DJ (1996) Isoniazid related fatal hepatitis. West J Med 164:486-491
17. McGlynn KA (1986) Isoniazid prophylaxis in hepatitis B-carriers. Am Rev Respir Dis 134:666-668
18. Siskind MS (1993) Isoniazid-induced neurotoxicity in chronic dialysis patients: Report of 3 cases and a review of the literature. Nephron 64:303-306